Novem Group’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.61M Sell
6,029
-2,265
-27% -$688K 0.26% 91
2026
Q1
$1.77M Buy
8,294
+569
+7% +$127K 0.2% 96
2025
Q4
$1.32M Sell
7,725
-9,194
-54% -$1.43M 0.15% 117
2025
Q3
$2.27M Buy
16,919
+104
+0.6% +$11K 0.27% 81
2025
Q2
$1.64M Sell
16,815
-3,103
-16% -$246K 0.21% 87
2025
Q1
$1.45M Buy
19,918
+3,709
+23% +$292K 0.2% 91
2024
Q4
$1.17M Buy
+16,209
New +$1.23M 0.17% 106

Other funds holding LRCX

Novem Group's LRCX Position: Q2 2026 in Review

Novem Group reduced its Lam Research (LRCX) stake by 27% in Q2 2026, selling an estimated $688K and leaving 6,029 shares worth $2.61M. The position accounts for 0.26% of the portfolio, ranked #91.

Novem Group first reported a position in LRCX in Q4 2024 and has held it in 7 quarters since. 3,123 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Novem Group held 6,029 shares of Lam Research worth $2.61M as of Q2 2026.
  • Novem Group sold 2,265 Lam Research shares in Q2 2026, an estimated $688K.
  • Lam Research made up 0.26% of Novem Group's portfolio in Q2 2026, its #91 holding.
  • Novem Group first reported a position in Lam Research in Q4 2024 and has held it in 7 quarters since.
  • 3,123 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.